---
figid: PMC11040904__40164_2024_515_Figb_HTML
figtitle: Regulatory pathways governing PD-L1 via phosphorylation and ubiquitination
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11040904
filename: PMC11040904__40164_2024_515_Figb_HTML.jpg
figlink: /pmc/articles/PMC11040904/figure/F2
number: F2
caption: Regulatory pathways governing PD-L1 via phosphorylation and ubiquitination.
  a In combination with JAK1, GSK3β, AMPK, EGF, STT3A, and IL-6 collaboratively facilitate
  serine/threonine phosphorylation of PD-L1, leading to subsequent ubiquitination.
  b β-TrCP, C-Cbl, Cbl-b, and DHA contribute to the increase in PD-L1 ubiquitination.
  Conversely, IFIT1 impedes PD-L1 ubiquitination. CDK4/6 enhances PD-L1 ubiquitination
  via SPOP. The E3 ubiquitin ligase HUWE1, in conjunction with PD-L1, facilitates
  PD-L1 ubiquitination. STUB1 stimulates PD-L1 ubiquitination, leading to subsequent
  degradation, while CMTM6/4 impedes the binding of PD-L1 to STUB1, thereby downregulating
  PD-L1 ubiquitination. Casp8 promotes PD-L1 ubiquitination by upregulating TNFAIP3.
  USP2 modulates the stability of VPRBP and facilitates PD-L1 ubiquitination. MIB2
  catalyzes PD-L1 ubiquitination, mediating the trafficking of PD-L1 from the trans-Golgi
  network to the membrane through RAB8. Circular RNA-0000512 promotes PD-L1 ubiquitination
  by suppressing CMTM6 expression, while circular RNA-0067842 inhibits PD-L1 ubiquitination
  by upregulating CMTM6. The black arrows indicate positive regulation, and the red
  arrows indicate negative regulation
papertitle: 'Emerging therapeutic frontiers in cancer: insights into posttranslational
  modifications of PD-1/PD-L1 and regulatory pathways'
reftext: Rong Wang, et al. Exp Hematol Oncol. 2024;13(NA).
year: '2024'
doi: 10.1186/s40164-024-00515-5
journal_title: Experimental Hematology & Oncology
journal_nlm_ta: Exp Hematol Oncol
publisher_name: BioMed Central
keywords: PD-1 | PD-L1 | Posttranslational modification | Immunotherapy
automl_pathway: 0.9460602
figid_alias: PMC11040904__F2
figtype: Figure
redirect_from: /figures/PMC11040904__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11040904__40164_2024_515_Figb_HTML.html
  '@type': Dataset
  description: Regulatory pathways governing PD-L1 via phosphorylation and ubiquitination.
    a In combination with JAK1, GSK3β, AMPK, EGF, STT3A, and IL-6 collaboratively
    facilitate serine/threonine phosphorylation of PD-L1, leading to subsequent ubiquitination.
    b β-TrCP, C-Cbl, Cbl-b, and DHA contribute to the increase in PD-L1 ubiquitination.
    Conversely, IFIT1 impedes PD-L1 ubiquitination. CDK4/6 enhances PD-L1 ubiquitination
    via SPOP. The E3 ubiquitin ligase HUWE1, in conjunction with PD-L1, facilitates
    PD-L1 ubiquitination. STUB1 stimulates PD-L1 ubiquitination, leading to subsequent
    degradation, while CMTM6/4 impedes the binding of PD-L1 to STUB1, thereby downregulating
    PD-L1 ubiquitination. Casp8 promotes PD-L1 ubiquitination by upregulating TNFAIP3.
    USP2 modulates the stability of VPRBP and facilitates PD-L1 ubiquitination. MIB2
    catalyzes PD-L1 ubiquitination, mediating the trafficking of PD-L1 from the trans-Golgi
    network to the membrane through RAB8. Circular RNA-0000512 promotes PD-L1 ubiquitination
    by suppressing CMTM6 expression, while circular RNA-0067842 inhibits PD-L1 ubiquitination
    by upregulating CMTM6. The black arrows indicate positive regulation, and the
    red arrows indicate negative regulation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRRK2
  - CD274
  - IL6
  - JAK1
  - GSK3A
  - GSK3B
  - BTRC
  - MIB2
  - EGF
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - STT3A
  - APC
  - PROC
  - RAB8A
  - CASP8
  - TNFAIP3
  - RNF125
  - IFIT1
  - SPOP
  - CDK4
  - CDK6
  - DCAF1
  - USP2
  - RIGI
  - CBL
  - CBLB
  - TMUB1
  - HUWE1
  - CMTM6
  - STUB1
  - CMTM4
  - ELAVL1
  - SLC5A2
  - EGF
  - DHA
---
